Evaxion establishes new AI-derived precision cancer vaccine concept
12 déc. 2024 08h00 HE
|
Evaxion Biotech
Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical data confirms the...
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress
02 déc. 2024 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, December 2, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present...
Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2
09 sept. 2024 07h00 HE
|
Evaxion Biotech
New pre-clinical data demonstrates that the novel EVX-B2 mRNA vaccine candidate triggers a targeted immune response The specific immune response leads to the elimination of the gonorrhea bacteriaThe...
Siyata Mobile Inc. to Showcase Portfolio at IWCE 2024
11 mars 2024 11h43 HE
|
Siyata Mobile Inc.
Siyata Mobile (NASDAQ:SYTA) will host an exhibitor's booth at the International Wireless Communications Expo ("IWCE") 2024 in partnership with Verizon
Siyata Receives First Order for SD7 Handsets in Higher Education
20 déc. 2023 08h59 HE
|
Siyata Mobile Inc.
VANCOUVER, British Columbia, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC)...
A Year End Message from Marc Seelenfreund, Siyata Mobile’s CEO
12 déc. 2023 08h05 HE
|
Siyata Mobile Inc.
VANCOUVER, British Columbia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular (PoC) devices and...
Siyata Mobile Announces $900,000 Follow-On Orders
07 déc. 2023 10h48 HE
|
Siyata Mobile Inc.
Siyata Mobile Inc. (Nasdaq: SYTA) received a $900,000 order for existing international Defense and EMS customers for the Company’s UV350 and PTT devices
Global In-Vitro Diagnostics Market Size is Projected to Reach USD 116.32 Billion by 2030, with a CAGR of 5.2%: Straits Research
31 oct. 2023 14h50 HE
|
Straits Research
New York, United States, Oct. 31, 2023 (GLOBE NEWSWIRE) -- In-vitro diagnostics, or IVD, are medical devices and reagents used to examine body fluids and tissues to diagnose diseases, conditions,...
Point of Care Diagnostics Market to Hit 12.7% CAGR with Glucose Monitoring Products Driving Growth During 2021–2028 | The Insight Partners
26 oct. 2023 07h55 HE
|
The Insight Partners
Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates in disease diagnosis, monitoring,...
Albumin & Creatinine Tests Market revenue to hit USD 19 Billion by 2035, says Research Nester
22 août 2023 07h30 HE
|
Research Nester
New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Albumin & Creatinine Tests market size is slated to expand at ~19% CAGR between 2023 and 2035. The market is poised to garner a revenue of...